Neoplasms, Endometrial Terminated Phase 2 Trials for Gedatolisib (DB11896)

Also known as: Endometrial Neoplasm / Endometrial Neoplasms / Endometrial neoplasia / Endometrial neoplasm NOS / Neoplasm endometrium / Neoplasm of endometrium

IndicationStatusPhase
DBCOND0034079 (Neoplasms, Endometrial)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01420081A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial CancerTreatment